This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Organization-level Youth Engagement Approach for Substance Misuse Prevention

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05736211
Recruitment Status : Recruiting
First Posted : February 21, 2023
Last Update Posted : March 25, 2024
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Wake Forest University Health Sciences

Brief Summary:
Phase 1 will consist of a small pilot Open Trial (OT). The objective of Phase 1 is to develop an organization-level YE prevention strategy and implement it in a community-based organization to test feasibility and acceptability in an open trial with one organization. This will include developing a manual for systematically incorporating YE into prevention efforts in community settings. Phase 2 will consist of a small pilot Randomized Controlled Trial (RCT). Four prevention organizations will be randomized either to include Youth Engagement in prevention efforts (treatment) or not (control). The study team will attempt to match the treatment and control groups on relevant characteristics such as geographic location (e.g., urban, rural), population served (e.g., church-based, school-based), and/or prior Youth Engagement involvement. The objective of the second phase of this study is to evaluate the preliminary effectiveness of Youth Engagement (YE) as a prevention strategy for opioid misuse in a small pilot randomized control trial (RCT). This pilot study will examine the effects of the YE prevention strategy on (a) organization-level outcomes, such as perceived value added to prevention programming and (b) individual-level outcomes such as personal skills and attitudes as well as knowledge and attitudes about substances including opioids. Up to 15 leaders/staff and 45 youth/young adults (60 people overall) will be recruited for the study.

Condition or disease Intervention/treatment Phase
Drug Use Substance Use Opioid Use Substance Misuse Behavioral: Organization-level Youth Engagement prevention strategy Not Applicable

Detailed Description:

Background, Rationale and Context Substance misuse is a major public health problem and opioid misuse is an acute problem in rural and high poverty communities. Adolescence and young adulthood is a formative time for positive social development, as young people increase their needs for maturity and autonomy, define their identities, and carve out their roles in society. But many young adults (YAs) are isolated within communities, feel that they do not matter, and lack meaningful opportunities to engage with society and form positive connections with prosocial institutions. Further, community systems and settings that serve YAs often do not effectively involve them. Engaging YAs in their communities and in the prevention systems targeting substance misuse may prevent the use of substances by targeting two pathways. The first is an individual pathway via bolstering psychosocial development and reducing risks for opioids by providing YAs with meaningful prosocial opportunities to fulfill developmental needs. The second is an environmental pathway via affecting health system and community-based settings through improving prevention efforts targeting YAs. This project tests an organization-level Youth Engagement (YE) approach to improve prevention.

Only organizations randomized to treatment will include youth/YA participants. Youth/YA survey data will be collected at the start of their participation in the YE strategy (pre-YE) and 6 months later (post-YE). At the post-YE the study team will interview a subset of interested YE group participants to qualitatively assess their experiences and to identify, in their own voices, what aspects of YE emerge as important to youth development and their health-related decision-making.

The timeframe for this phase will be 12-18 months.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Organization-level Youth Engagement Approach for Substance Misuse Prevention
Actual Study Start Date : March 14, 2024
Estimated Primary Completion Date : October 2025
Estimated Study Completion Date : October 2025

Arm Intervention/treatment
Experimental: Phase 2 intervention
In this arm the study will implement an organization-level Youth Engagement prevention strategy by systematically incorporating Youth Engagement into prevention efforts in a community setting.
Behavioral: Organization-level Youth Engagement prevention strategy
Systematically incorporating Youth Engagement into prevention efforts in a community setting

No Intervention: Phase 2 control
This arm will receive no intervention. Control group organizations will continue their normal prevention strategy without the inclusion of a Youth Engagement component



Primary Outcome Measures :
  1. Staff Surveys--YE Prevention Programming Value [ Time Frame: Month 6 ]
    This outcome will be assessed through a survey measure administered to the organization leaders and staff in the YE intervention organizations only. The survey measures will be on a 1-5 scale with a higher score meaning a higher perceived programming value. Results will be reported as mean/SD.

  2. Retention Percentage of Youth/Young Adults in YE Prevention Programming [ Time Frame: Month 6 ]
    This outcome will be assessed through a survey measure administered to the organization leaders and staff in the YE intervention organizations only. It will be reported as count/percent.

  3. Perceived Usefulness of YE prevention [ Time Frame: Month 6 ]
    This outcome will be assessed through a survey measure administered to the organization leaders and staff in the YE intervention organizations only. The survey items will ask about perceived usefulness of the YE intervention for youth/young adults, the organization, and the community. Items will be on a 1-5 scale with higher scores indicating higher perceived usefulness. Results will be reported as mean/SD.

  4. Perceived effectiveness, quality, reach, and usefulness of general prevention approaches [ Time Frame: Month 6 ]
    This outcome will be assessed through a survey measure administered to the organization leaders and staff in the YE intervention organizations and comparison organizations. The survey measures will be on a 1-5 scale with higher scores indicating higher perceived quality, reach, and usefulness. Results will be reported as mean/SD.


Secondary Outcome Measures :
  1. Youth/young adults: leadership and communication skills [ Time Frame: Baseline and Month 6 ]
    This outcome will be assessed through a survey measure administered to YAs involved in the YE intervention at baseline (pre-YE) and 6 months later (post-YE). The survey measures will be on a 1-5 scale with higher scores indicating greater leadership and communication skills and results reported as change in means from pre to post intervention.

  2. Youth/young adults: self-efficacy [ Time Frame: Baseline and Month 6 ]
    This outcome will be assessed through a survey measure administered to YAs involved in the YE intervention at baseline (pre-YE) and 6 months later (post-YE). The survey measures will be on a 1-5 scale with higher scores indicating higher self-efficacy and results reported as change in means from pre to post intervention.

  3. Youth/young adults: self esteem [ Time Frame: Baseline and Month 6 ]
    This outcome will be assessed through a survey measure administered to YAs involved in the YE intervention at baseline (pre-YE) and 6 months later (post-YE). The survey measures will be on a 1-5 scale with higher scores indicating greater self esteem and results reported as change in means from pre to post intervention.

  4. Youth/young adults: social connectedness [ Time Frame: Baseline and Month 6 ]
    This outcome will be assessed through a survey measure administered to YAs involved in the YE intervention at baseline (pre-YE) and 6 months later (post-YE). The survey measures will be on a 1-5 scale with higher scores indicating greater social connectedness and results reported as change in means from pre to post intervention.

  5. Youth/young adults: meaningful social role [ Time Frame: Baseline and Month 6 ]
    This outcome will be assessed through a survey measure administered to YAs involved in the YE intervention at baseline (pre-YE) and 6 months later (post-YE). The survey measures will be on a 1-5 scale with higher scores indicating higher perceived meaningful social role and results reported as change in means from pre to post intervention.

  6. Youth/young adults: beliefs and intentions related to substance use [ Time Frame: Baseline and Month 6 ]
    This outcome will be assessed through a survey measure administered to YAs involved in the YE intervention at baseline (pre-YE) and 6 months later (post-YE). The survey measures will be on a 1-5 scale with higher scores indicating safer beliefs and intentions and results reported as change in means from pre to post intervention.


Other Outcome Measures:
  1. Exploratory--YE Prevention Programming Value, Qualitative [ Time Frame: Month 6 ]
    This exploratory outcome will be assessed qualitatively through interviews with organizational leaders and staff

  2. Exploratory--Retention of Youth/Young Adults in YE Prevention Programming, Qualitative [ Time Frame: Month 6 ]
    This exploratory outcome will be assessed qualitatively through interviews with organizational leaders and staff

  3. Exploratory--Reach of YE Prevention Efforts in the Community, Qualitative [ Time Frame: Month 6 ]
    This exploratory outcome will be assessed qualitatively through interviews with organizational leaders and staff

  4. Exploratory--Perceived Usefulness of YE prevention, Qualitative [ Time Frame: Month 6 ]
    This exploratory outcome will be assessed qualitatively through interviews with organizational leaders and staff

  5. Exploratory--Perceived effectiveness, quality, reach, and usefulness of general prevention approaches, Qualitative [ Time Frame: Month 6 ]
    This exploratory outcome will be assessed qualitatively through interviews with organizational leaders and staff



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   16 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

INCLUSION CRITERIA:

Organizational leaders/staff:

  • Leaders or staff of community-based prevention organizations based in North Carolina
  • Organizations are youth/young adult-serving and focused on opioid misuse prevention
  • Organizations demonstrate readiness, interest, need, and resources to invest in Youth Engagement as part of prevention
  • Leaders or staff are or would be involved in implementing Youth Engagement strategy at the organization
  • Leaders or staff are able to speak and read English fluently

Youth/young adult participants involved with organizations:

  • Adolescents and young adults age 16 - 29
  • Engaged as volunteers with the organization's opioid misuse prevention efforts
  • Able to speak and read English fluently

EXCLUSION CRITERIA:

• Organizations already incorporating a high level of Youth Engagement in its prevention work


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05736211


Contacts
Layout table for location contacts
Contact: Parissa J Ballard, PhD 336-716-0793 pballard@wakehealth.edu
Contact: Taylor Arnold 336-713-5019 tjarnold@wakehealth.edu

Locations
Layout table for location information
United States, North Carolina
Wake Forest School of Medicine Recruiting
Winston-Salem, North Carolina, United States, 27157
Contact: Parissa J Ballard, PhD    336-716-0793    pballard@wakehealth.edu   
Contact: Taylor Arnold    336-713-5019    tjarnold@wakehealth.edu   
Principal Investigator: Parissa Ballard, PhD         
Sponsors and Collaborators
Wake Forest University Health Sciences
National Institute on Drug Abuse (NIDA)
Investigators
Layout table for investigator information
Principal Investigator: Parissa J Ballard, PhD Wake Forest University Health Sciences
Publications of Results:
Eccles, J. S. et al. Control versus autonomy during early adolescence. Journal of Social Issues 47, 53-68 (1991).

Other Publications:
Layout table for additonal information
Responsible Party: Wake Forest University Health Sciences
ClinicalTrials.gov Identifier: NCT05736211    
Other Study ID Numbers: IRB00091590
5K01DA048201-03 ( U.S. NIH Grant/Contract )
First Posted: February 21, 2023    Key Record Dates
Last Update Posted: March 25, 2024
Last Verified: January 2024
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: There is not a plan to make IPD available. The information collected about organizations and from individual participants will be kept confidential; only aggregate results will be reported in manuscripts and reports.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Wake Forest University Health Sciences:
Adolescents
Young adults
Prevention
Youth Engagement
Randomized control trial
Additional relevant MeSH terms:
Layout table for MeSH terms
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders